Y. Takeishi et al., Effect of angiotensin-converting enzyme inhibition on protein kinase C andSR proteins in heart failure, AM J P-HEAR, 45(1), 1999, pp. H53-H62
Citations number
37
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
We tested the hypothesis that activation of protein kinase C (PKC) isoforms
in pressure-overload heart failure was prevented by angiotensin-converting
enzyme (ACE) inhibition, resulting in normalization of cardiac sarcoplasmi
c reticulum (SR) Ca2+ ATPase (SERCA) 2a and phospholamban protein levels an
d improvement in intracellular Ca2+ handling. Aortic-banded and control gui
nea pigs were given ramipril (5 mg . kg(-1). day(-1)) or placebo for 8 wk.
Ramipril-treated banded animals had lower left ventricular (LV) and lung we
ight, improved survival, increased isovolumic LV mechanics, and improved ca
rdiomyocyte Ca2+ transients compared with placebo-treated banded animals. T
his was associated with maintenance of SERCA2a and phospholamban protein ex
pression. Translocation of PKC-alpha and -epsilon was increased in placebo-
treated banded guinea pigs compared with controls and was attenuated signif
icantly by treatment with ramipril. We conclude that ACE inhibition attenua
tes PKC translocation and prevents downregulation of Ca2+ cycling protein e
xpression in pressure-overload hypertrophy. This represents a mechanism for
the beneficial effects of this therapy on LV function and survival in hear
t failure.